D-0576-2025 Class II Ongoing
FDA drug recall D-0576-2025 was initiated by Ascend Laboratories, LLC on Jul 21, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications: low dissolution results The recall status is ongoing. Affected quantity: 8,568 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 20, 2025
- Initiation Date
- Jul 21, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,568 bottles
Product description
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30
Reason for recall
Failed Dissolution Specifications: low dissolution results
Distribution pattern
Nationwide in the USA
Code information
Lot 23121560, Exp 4/30/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0576-2025
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Ascend Laboratories, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.